Enanta Pharma (ENTA) Misses Q3 EPS by 6c

Enanta Pharma (NASDAQ: ENTA) reported Q3 EPS of $0.13, $0.06 worse than the analyst estimate of $0.19.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
• Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating